SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EYES Second Sight-Eyeglasses for the Blind help them see
An SI Board Since November 2014
Posts SubjectMarks Bans Symbol
99 9 0 EYES
Emcee:  Savant Type:  Moderated
Second Sight
How Does Argus® II Produce Sight?
In a healthy eye, the photoreceptors (rods and cones) in the retina convert light into tiny electrochemical impulses that are sent through the optic nerve and into the brain, where they are decoded into images. If the photoreceptors no longer function correctly—due to conditions such as retinitis pigmentosa—the first step in this process is disrupted, and the visual system cannot transform light into images.

The Argus II Retinal Prosthesis System ("Argus II") bypasses the damaged photoreceptors altogether. A miniature video camera housed in the patient’s glasses captures a scene. The video is sent to a small patient-worn computer (i.e., the video processing unit – VPU) where it is processed and transformed into instructions that are sent back to the glasses via a cable. These instructions are transmitted wirelessly to an antenna in the implant. The signals are then sent to the electrode array, which emits small pulses of electricity. These pulses bypass the damaged photoreceptors and stimulate the retina’s remaining cells, which transmit the visual information along the optic nerve to the brain, creating the perception of patterns of light. Patients learn to interpret these visual patterns.

2-sight.eu
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
99 THEIR BIONIC EYES ARE NOW OBSOLETE AND UNSUPPORTED Second Sight left users of Glenn Petersen12/21/2022
98Doctors Are Preparing to Implant the World’s First Human Bionic Eye The same imGlenn Petersen19/16/2020
97A human user of the bionic eye would gain night vision capabilities, researchersGlenn Petersen15/21/2020
96Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic anJulius Wong-4/11/2019
95Raised more than I thought. Most of it came from the Chairman. I decide to partRocky9-2/21/2019
94Another rights offering - finance.yahoo.com Again Chairman has indication that Rocky9-1/7/2019
93$10MM from chairman - finance.yahoo.com Rocky9-5/7/2018
92RT..Argus II depended upon the eye having some functional retinal cells...this mSavant-3/20/2018
91Second Sight EPS in-line, beats on revenue Second Sight (NASDAQ: EYES): Q4 EPS Julius Wong-3/7/2018
90Second Sight Announces Latest Expansion of Medicare Coverage for Argus II RetinaJulius Wong-3/6/2018
89Second Sight Announces Market Entry into Singapore with First Implant of Argus IJulius Wong-2/16/2018
88Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems ImplJulius Wong12/5/2018
87He is bullish stocktwits.comJulius Wong-12/10/2017
86And the question (probably unanswerable) is: WHY? EYES + EYESW = 1.75 + .63 = 2Rocky9-12/9/2017
85<img src='http://elite.finviz.com/publish/120917/EYESccdl09126277.png'Julius Wong-12/9/2017
84WOW - big move over last couple days. I am now positive on the last offering - Rocky9-12/4/2017
83Ontario Health Technology Advisory Committee Recommends Public Funding for SeconJulius Wong-11/10/2017
82Expedited Access Pathway Designation for the Orion Cortical Visual Prosthesis SyJulius Wong-11/8/2017
81Second Sight on go to start study of Orion Cortical Visual Prosthesis The FDA haJulius Wong-11/2/2017
80Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical StudJulius Wong111/2/2017
79Bullish crossover in MACD and Stochatics. [graphic]hollyhunter-9/25/2017
78Second Sight perks up on article about Orion implant in MIT journal; shares up 4Julius Wong-9/18/2017
77Second Sight board member reports 42% stake, shares up 15% Thinly traded nano caJulius Wong-9/11/2017
76Second Sight Receives Conditional FDA Approval to Begin First Orion Human ClinicJulius Wong18/28/2017
75Medicare reimbursement for Second Sight's Argus may drop 19% next year The UJulius Wong-7/14/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):